glp-1 in pregnancy JCI Insight Preconception GLP-1 Use Not Linked

10.1186/s12933-021-01366-8 20 GotoH.NomiyamaT.MitaT.YasunariE.AzumaK.KomiyaK.et al (2011)

Pregnancy medications

About CT-996 study 6 The CT-996-201 trial (NCT05814107) is a multi-part, multi-cohort Phase I randomised, double-blind, placebo-controlled, single- and multiple- ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of CT-996 in otherwise-healthy adults who are overweight or obese, with and without type 2 diabetes

As it is not fully approved, most of what we know about its safety and side effects emerges from ongoing and recent clinical trials

[DOI] [PMC free article] [PubMed] [Google Scholar] 480.Giugliano, D

Strengths: Lowest floor price on the list at $129, on the no-commitment plan